Om

Jupiter Neurosciences Inc. is a clinical-stage pharmaceutical company focused on developing therapies for neuroinflammation and related central nervous system disorders. Based in Jupiter, Florida and founded in 2015, the company is built around a proprietary resveratrol-based drug platform designed to deliver this compound in a more effective and bioavailable oral form. Its lead product candidate, JOTROL, targets a broad range of conditions where neuroinflammation is a key component, including various neurodegenerative and rare diseases. Jupiter Neurosciences also integrates its platform into consumer-oriented longevity and wellness formulations under the Nugevia brand, addressing areas such as mitochondrial support, cognitive health, and skin vitality. Operating within the healthcare and biotechnology sectors, the company primarily serves unmet medical needs in CNS and rare disease markets, positioning its resveratrol platform at the intersection of clinical therapeutics and scientifically grounded wellness solutions.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I JUPITER NEUROSCIENCES MED ENDAVU: Køb Jupiter Neurosciences ($JUNS) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Jupiter Neurosciences, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.